Summary
Marketwise NASDAQ:MKTW Chief Financial Officer Erik Mickels completed a sale of 6,000 shares of the companys Class A common stock on March 23, 2026, generating $88,200 in gross proceeds. The sale was transacted at a weighted average price of $14.70 per share, with individual trades ranging from $14.50 to $15.44. Following the disposition, Mickels directly holds 79,064 shares of Marketwise.
Transaction details
The filing shows a single-day disposition of 6,000 Class A shares. The reported weighted average price of $14.70 is derived from the differing execution prices within the stated range of $14.50 to $15.44. The post-transaction share count attributed to Mickels is 79,064 shares, held directly.
Company results cited alongside the sale
In the context of the insider sale, MarketWise also released its fourth quarter 2025 financial results. The company reported adjusted earnings per share of $0.76 and revenue of $83.4 million for the quarter. Revenue for the period declined 14.4% compared with the same quarter in the prior year. At the same time, MarketWise said it exceeded its full-year 2025 guidance for billings and cash flow from operating activities.
Billing growth contrasts with revenue decline
MarketWise highlighted a notable divergence between revenue and billings in the fourth quarter. The company reported fourth quarter billings of $78.9 million, representing a 42% increase year-over-year. The company framed these figures as evidence of robust billing expansion, even as reported revenue fell versus the prior-year quarter.
Key points
- Erik Mickels sold 6,000 Class A shares on March 23, 2026, for $88,200 in total proceeds.
- MarketWise reported Q4 2025 adjusted EPS of $0.76 and revenue of $83.4 million, a 14.4% year-over-year decline.
- Fourth quarter billings rose 42% year-over-year to $78.9 million, and the company exceeded full-year 2025 guidance for billings and operating cash flow.
Sectors potentially affected
- Equities - insider transactions and quarterly results can influence investor perception and trading activity in the companys stock.
- Corporate finance and reporting - the divergence between billings growth and revenue decline bears on financial analysis and cash-flow assessment.
Risks and uncertainties
- The filing does not state a reason for the insider sale, leaving interpretation of the trade open and creating uncertainty for investors evaluating intent.
- Revenue declined 14.4% year-over-year in the fourth quarter, indicating a potential risk to top-line stability despite stronger billings.
- While billings grew 42% year-over-year and the company exceeded full-year guidance for billings and operating cash flow, the sustainability of this billing growth relative to reported revenue is not addressed in the filing.
What is clear from the filings
The public disclosures establish the sale details, the post-transaction holdings of the CFO, and the companys reported financial results for the quarter. They do not provide additional commentary explaining the insider sale or reconciling the divergence between billings growth and declining revenue beyond the figures disclosed.